 | Connie Henke Yarbro, Michelle Goodman, Margaret Hansen Frogge - 2005 - 1928 páginas
...2002 222. Druker BJ: Imatinib as a paradigm of targeted therapies./ Clin Oncol 21:239S-245S, 2003 223. Goldman JM, Meló JV: Chronic myeloid leukemia: advances...biology and new approaches to treatment. N Engl J Med 349:1451-1464, 2003 224. Kurzrock R, Kantarjian JM, Druker BJ, et al: Philadelphia chromosome-positive... | |
 | Connie Henke Yarbro, Michelle Goodman, Margaret Hansen Frogge - 2005 - 1928 páginas
...Imatinib as a paradigm of targeted therapies. J Clin Oncoí21:239S-245S, 2003 223. Goldman JM, MeloJV: Chronic myeloid leukemia: advances in biology and new approaches to treatment. N Engl J Med 349:1451-1464, 2003 224. Kurzrock R, Kantarjian JM, Druker BJ, et al: Philadelphia chromosome-positive... | |
 | Connie Henke Yarbro, Michelle Goodman, Margaret Hansen Frogge - 2005 - 1928 páginas
...Imatinib as a paradigm of targeted therapies, у Сип Oncoí21:239S-245S, 2003 223. Goldman JM, MeloJV: Chronic myeloid leukemia: advances in biology and new approaches to treatment. N Engl J Med 349:1451-1464, 2003 224. Kurzrock R, Kantaijian JM, Druker BJ, et al: Philadelphia chromosome-positive... | |
 | Harry Iland, Mark Hertzberg, Paula Marlton - 2008 - 308 páginas
...dilution of DAPI with extra antifade solution is advised. References 1. Goldman, JM and Melo, JV (2003) Chronic myeloid leukemia — advances in biology and new approaches to treatment. N. Engl. J. Med. 349, 1451-1464. 2. Chase, A., Grand, F., Zhang, JG, Blackett, N., Goldman, J., and Gordon, M. (1997)... | |
 | R.J. Trent - 2005 - 319 páginas
...Journal of Haematology 2003; 121 :823-838 (overview of this topic particularly in the acute leukaemias). Goldman JM, Meló JV. Chronic myeloid leukemia —...advances in biology and new approaches to treatment. New England Journal of Medicine 2003; 349:1451-1464 (comprehensive summary of chronic myeloid leukaemia).... | |
 | Doriano Fabbro, Frank McCormick - 2007 - 599 páginas
...TEL- JAK transgenic mice develop T-cell leukemia. Blood 2000; 95(12):3891-3899. 82. Goldman JM, Melo JV. Chronic myeloid leukemia — advances in biology and new approaches to treatment. N EnglJ Med 2003; 349(15):1451-1464. 83. Joos S, Kupper M, Ohl S, et al. Genomic imbalances including... | |
 | R.J. Trent - 2005 - 319 páginas
...2003; 121 :823-838 (overview of this topic particularly in the acute leukaemias). Goldman JM, Melo JV. Chronic myeloid leukemia — advances in biology and new approaches to treatment. New England lournal of Medicine 2003; 349:1451-1464 (comprehensive summary of chronic myeloid leukaemia).... | |
 | Mark F. Ditmar - 2006 - 772 páginas
...tratamiento definitivo actual de la LMC sigue siendo el trasplante de células madre. Goldman JM, Melo JV: Chronic myeloid leukemia — Advances in biology and new approaches to treatment. N Engl J Med 349:1451-1464, 2003. 82. En los niños con recuentos de leucocitos muy elevados, ¿por qué son más... | |
 | Wojciech Gorczyca - 2005 - 332 páginas
...clustered within a limited region, ber, on chromosome 22. Cell 1984:36:93-9 1343. Goldman JM, Melo JV. Chronic myeloid leukemia advances in biology and new approaches to treatment. N Engl J Med 2003:349:1451-64 1344. Sawyers CL. Chronic myeloid leukemia. N Engl J Med 1999:340:1330-40 1345. Sokal... | |
 | Carie Ann Braun, Cindy Miller Anderson - 2007 - 550 páginas
...non-Hodgkin's lymphoma. N Engl J Blood 2001 ;98: 13 12-1320. Med 1993;328:1023-1030. 34. GoldmanJ, Melo J. Chronic myeloid leukemia: advances in biology and new approaches to treatment. N Engl J Med 2003;349: 1451-1464. RECOMMENDED REVIEW This chapter relies heavily on your understanding of the primacy... | |
| |
JV: Chronic myeloid leukemia: advances in biology and new approaches to treatment. N Engl J Med 349:1451-1464, 2003 224. 
